Transcript Pharmacy receives ACHC accreditation
JACKSON, Miss. A pharmacy that specializes in serving patients with chronic medical conditions has received accreditation status from the Accreditation Commission for Health Care for specialty pharmacy services.
Transcript Pharmacy said Wednesday it was awarded ACHC accreditation, a voluntary activity where healthcare organizations submit to peer review of their internal policies, processes and patient care delivery against national standards. Transcript recently was involved in a year-long study conducted by Virginia Commonwealth University, which showed that through personalized communication with each patient, Transcript improved compliance.
“This recognition demonstrates that the level of care and quality of services we offer bring significant benefits to the patients that we serve,” said company president Cliff Osbon.
Cardiovascular, diabetes risk associated with prostate cancer drug class
SILVER SPRING, Md. Patients taking a certain class of drugs mostly used for prostate cancer may be at higher risk of heart disease and diabetes, the Food and Drug Administration warned on Wednesday.
The FDA said it would require manufacturers to add new warnings to gonadotropin-releasing hormone agonists. GnRH agonists suppress the production of testosterone and are used in androgen-deprivation therapy in men with prostate cancer. Some of the drugs also are used to treat women with endometriosis and children with precocious puberty. GnRH agonists include Abbott’s Lupron (leuprolide acetate), Sanofi-Aventis’ Eligard (leuprolide acetate), Watson Pharmaceuticals’ Trelstar (triptorelin pamoate) and several other branded and generic drugs.
The agency said in May that analyses had found that patients taking GnRH agonists had a small increased risk for diabetes, heart attack, stroke and sudden death.
Good Neighbor Pharmacy donates funds to pharmacy schools
VALLEY FORGE, Pa. AmerisourceBergen and its community pharmacy network program, Good Neighbor Pharmacy, will fund several education and scholarship programs for pharmacy students, the company said Wednesday.
AmerisourceBergen said the funding, pledged over the last few weeks, brought the total amount of money given to support the programs to more than $2 million.
“AmerisourceBergen is committed to supporting the practice of community pharmacy,” president and CEO Dave Yost said. “Community-based pharmacists are critical members of the evolving U.S. healthcare system and the most accessible professional of the patient’s healthcare team. We are pleased to encourage students to consider community pharmacy and retail entrepreneurship, and to continue this tradition of supportive care.”